163 related articles for article (PubMed ID: 24675502)
21. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
Shao YY; Hong RL
Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
[TBL] [Abstract][Full Text] [Related]
22. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.
Dahabreh I; Tsoutsos G; Tseligas D; Janinis D
BMC Clin Pharmacol; 2006 Sep; 6():5. PubMed ID: 16968538
[TBL] [Abstract][Full Text] [Related]
23. Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil-Induced Cardiac Vasospasm.
Vargo CA; Blazer M; Reardon J; Gulati M; Bekaii-Saab T
Clin Colorectal Cancer; 2016 Jun; 15(2):e61-3. PubMed ID: 26701613
[No Abstract] [Full Text] [Related]
24. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
Curtis BR; Kaliszewski J; Marques MB; Saif MW; Nabelle L; Blank J; McFarland JG; Aster RH
Am J Hematol; 2006 Mar; 81(3):193-8. PubMed ID: 16493620
[TBL] [Abstract][Full Text] [Related]
25. [The major response of metastatic kidney cancer to the combination of oxaliplatin, 5-fluorouracil and folinic acid (FOX-FOL)].
Chauffert B; Bonnotte B; Chvetzoff G; Flesch M
Presse Med; 1998 May; 27(18):859. PubMed ID: 9767871
[No Abstract] [Full Text] [Related]
26. A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.
Ito I; Ito Y; Mizuno M; Suzuki Y; Yasuda K; Ozaki T; Kosugi T; Yasuda Y; Sato W; Tsuboi N; Maruyama S; Imai E; Matsuo S
Clin Exp Nephrol; 2012 Jun; 16(3):490-4. PubMed ID: 22450906
[TBL] [Abstract][Full Text] [Related]
27. [Successful management using laparoscopic splenectomy for splenomegaly and thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced rectal cancer].
Koike N; Ohshima Y; Takeuchi T; Arita S; Shinozaki E
Gan To Kagaku Ryoho; 2013 Jun; 40(6):815-7. PubMed ID: 23863666
[TBL] [Abstract][Full Text] [Related]
28. Liver resection after FOLFOX with bevacizumab.
Mickle M; Mulcahy MF
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
[No Abstract] [Full Text] [Related]
29. Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX.
Mori Y; Nishimura T; Kitano T; Yoshimura K; Matsumoto S; Kanai M; Hazama M; Ishiguro H; Nagayama S; Yanagihara K; Teramukai S; Chiba T; Sakai Y; Fukushima M
Oncology; 2010; 79(1-2):136-43. PubMed ID: 21150228
[TBL] [Abstract][Full Text] [Related]
30. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
Malik Z; Eng C
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
[No Abstract] [Full Text] [Related]
31. Acute renal failure related to oxaliplatin-induced intravascular hemolysis.
Ulusakarya A; Misra S; Haydar M; Habert H; Castagne V; Gumus Y; Delmas-Marsalet B; Machover D
Med Oncol; 2010 Dec; 27(4):1425-6. PubMed ID: 19565364
[TBL] [Abstract][Full Text] [Related]
32. 'Out of blue' Lhermitte's sign: three cases due to low cumulative doses of oxaliplatin.
Jurado JM; Pajares B; Olmos D; Sevilla I; Alba E
Ann Oncol; 2008 Dec; 19(12):2093-4. PubMed ID: 18977850
[No Abstract] [Full Text] [Related]
33. Organizing pneumonia with fatal outcome after adjuvant chemotherapy with FOLFOX.
Vargas A; Montironi C; Buxó E
Arch Bronconeumol; 2015 Nov; 51(11):610. PubMed ID: 26163115
[No Abstract] [Full Text] [Related]
34. Administration of oxaliplatin to a pregnant woman with rectal cancer.
Gensheimer M; Jones CA; Graves CR; Merchant NB; Lockhart AC
Cancer Chemother Pharmacol; 2009 Jan; 63(2):371-3. PubMed ID: 18357450
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer.
Fuse N; Doi T; Ohtsu A; Takeuchi S; Kojima T; Taku K; Tahara M; Muto M; Asaka M; Yoshida S
Jpn J Clin Oncol; 2007 Jun; 37(6):434-9. PubMed ID: 17656481
[TBL] [Abstract][Full Text] [Related]
36. Is acute dyspnea related to oxaliplatin administration?
Pasetto LM; Monfardini S
World J Gastroenterol; 2006 Sep; 12(36):5907-8. PubMed ID: 17007064
[TBL] [Abstract][Full Text] [Related]
37. Oxaliplatin-induced Evan's syndrome.
Earle CC; Chen WY; Ryan DP; Mayer RJ
Br J Cancer; 2001 Feb; 84(3):441. PubMed ID: 11161414
[No Abstract] [Full Text] [Related]
38. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
[TBL] [Abstract][Full Text] [Related]
39. Fatal pneumonitis induced by oxaliplatin.
Arévalo Lobera S; Sagastibeltza Mariñelarena N; Elejoste Echeberría I; Melé Olivé M; Egaña Otaño L; Basterretxea Badiola L; La Casta Muñoa A; Azkue Gabilondo M
Clin Transl Oncol; 2008 Nov; 10(11):764-7. PubMed ID: 19015075
[TBL] [Abstract][Full Text] [Related]
40. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
Twelves C
Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
